Association of Cohort and Individual Substance Use With Risk of Transitioning to Drug Use, Drug Use Disorder, and Remission From Disorder: Findings From the World Mental Health Surveys

Página do item simplificado
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorDEGENHARDT, Louisa
dc.contributor.authorBHARAT, Chrianna
dc.contributor.authorGLANTZ, Meyer D.
dc.contributor.authorSAMPSON, Nancy A.
dc.contributor.authorAL-HAMZAWI, Ali
dc.contributor.authorALONSO, Jordi
dc.contributor.authorBUNTING, Brendan
dc.contributor.authorCIA, Alfredo
dc.contributor.authorGIROLAMO, Giovanni de
dc.contributor.authorJONGE, Peter De
dc.contributor.authorDEMYTTENAERE, Koen
dc.contributor.authorGUREJE, Oye
dc.contributor.authorHARO, Josep Maria
dc.contributor.authorHARRIS, Meredith G.
dc.contributor.authorHE, Yanling
dc.contributor.authorHINKOV, Hristo
dc.contributor.authorKARAM, Aimee Nasser
dc.contributor.authorKARAM, Elie G.
dc.contributor.authorKIEJNA, Andrzej
dc.contributor.authorKOVESS-MASFETY, Viviane
dc.contributor.authorLASEBIKAN, Victor
dc.contributor.authorLEE, Sing
dc.contributor.authorLEVINSON, Daphna
dc.contributor.authorMEDINA-MORA, Maria Elena
dc.contributor.authorMNEIMNEH, Zeina
dc.contributor.authorNAVARRO-MATEU, Fernando
dc.contributor.authorPIAZZA, Marina
dc.contributor.authorPOSADA-VILLA, Jose
dc.contributor.authorSCOTT, Kate
dc.contributor.authorSTEIN, Dan J.
dc.contributor.authorTACHIMORI, Hisateru
dc.contributor.authorTINTLE, Nathan
dc.contributor.authorTORRES, Yolanda
dc.contributor.authorKESSLER, Ronald C.
dc.contributor.authorAGUILAR-GAXIOLA, Sergio
dc.contributor.authorAL-HAMZAWI, Ali
dc.contributor.authorAL-KAISY, Mohammed Salih
dc.contributor.authorALONSO, Jordi
dc.contributor.authorANDRADE, Laura Helena
dc.contributor.authorBENJET, Corina
dc.contributor.authorBORGES, Guilherme
dc.contributor.authorBROMET, Evelyn J.
dc.contributor.authorBRUFFAERTS, Ronny
dc.contributor.authorBUNTING, Brendan
dc.contributor.authorALMEIDA, Jose Miguel Caldas de
dc.contributor.authorCARDOSO, Graca
dc.contributor.authorCHATTERJI, Somnath
dc.contributor.authorCIA, Alfredo H.
dc.contributor.authorDEGENHARDT, Louisa
dc.contributor.authorDEMYTTENAERE, Koen
dc.contributor.authorFAYYAD, John
dc.contributor.authorFLORESCU, Silvia
dc.contributor.authorGIROLAMO, Giovanni de
dc.contributor.authorGUREJE, Oye
dc.contributor.authorHARO, Josep Maria
dc.contributor.authorHINKOV, Hristo
dc.contributor.authorHU, Chi-yi
dc.contributor.authorJONGE, Peter de
dc.contributor.authorKARAM, Aimee Nasser
dc.contributor.authorKARAM, Elie G.
dc.contributor.authorKAWAKAMI, Norito
dc.contributor.authorKESSLER, Ronald C.
dc.contributor.authorKIEJNA, Andrzej
dc.contributor.authorKOVESS-MASFETY, Viviane
dc.contributor.authorLEE, Sing
dc.contributor.authorLEPINE, Jean-Pierre
dc.contributor.authorLEVINSON, Daphna
dc.contributor.authorMCGRATH, John
dc.contributor.authorMEDINA-MORA, Maria Elena
dc.contributor.authorMNEIMNEH, Zeina
dc.contributor.authorMOSKALEWICZ, Jacek
dc.contributor.authorNAVARRO-MATEU, Fernando
dc.contributor.authorPENNELL, Beth-Ellen
dc.contributor.authorPIAZZA, Marina
dc.contributor.authorPOSADA-VILLA, Jose
dc.contributor.authorSCOTT, Kate M.
dc.contributor.authorSLADE, Tim
dc.contributor.authorSTAGNARO, Juan Carlos
dc.contributor.authorSTEIN, Dan J.
dc.contributor.authorHAVE, Margreet ten
dc.contributor.authorTORRES, Yolanda
dc.contributor.authorVIANA, Maria Carmen
dc.contributor.authorWHITEFORD, Harvey
dc.contributor.authorWILLIAMS, David R.
dc.contributor.authorWOJTYNIAK, Bogdan
dc.contributor.groupauthorWHO World Mental Hlth Survey Col
dc.date.accessioned2019-09-23T14:22:53Z
dc.date.available2019-09-23T14:22:53Z
dc.date.issued2019
dc.description.abstractImportanceLimited empirical research has examined the extent to which cohort-level prevalence of substance use is associated with the onset of drug use and transitioning into greater involvement with drug use. ObjectiveTo use cross-national data to examine time-space variation in cohort-level drug use to assess its associations with onset and transitions across stages of drug use, abuse, dependence, and remission. Design, Setting, and ParticipantsThe World Health Organization World Mental Health Surveys carried out cross-sectional general population surveys in 25 countries using a consistent research protocol and assessment instrument. Adults from representative household samples were interviewed face-to-face in the community in relation to drug use disorders. The surveys were conducted between 2001 and 2015. Data analysis was performed from July 2017 to July 2018. Main Outcomes and MeasuresData on timing of onset of lifetime drug use, DSM-IV drug use disorders, and remission from these disorders was assessed using the Composite International Diagnostic Interview. Associations of cohort-level alcohol prevalence and drug use prevalence were examined as factors associated with these transitions. ResultsAmong the 90027 respondents (48.1% [SE, 0.2%] men; mean [SE] age, 42.1 [0.1] years), 1 in 4 (24.8% [SE, 0.2%]) reported either illicit drug use or extramedical use of prescription drugs at some point in their lifetime, but with substantial time-space variation in this prevalence. Among users, 9.1% (SE, 0.2%) met lifetime criteria for abuse, and 5.0% (SE, 0.2%) met criteria for dependence. Individuals who used 2 or more drugs had an increased risk of both abuse (odds ratio, 5.17 [95% CI, 4.66-5.73]; P<.001) and dependence (odds ratio, 5.99 [95% CI, 5.02-7.16]; P<.001) and reduced probability of remission from abuse (odds ratio, 0.86 [95% CI, 0.76-0.98]; P=.02). Birth cohort prevalence of drug use was also significantly associated with both initiation and illicit drug use transitions; for example, after controlling for individuals' experience of substance use and demographics, for each additional 10% of an individual's cohort using alcohol, a person's odds of initiating drug use increased by 28% (odds ratio, 1.28 [95% CI, 1.26-1.31]). Each 10% increase in a cohort's use of drug increased individual risk by 12% (1.12 [95% CI, 1.11-1.14]). Conclusions and RelevanceBirth cohort substance use is associated with drug use involvement beyond the outcomes of individual histories of alcohol and other drug use. This has important implications for understanding pathways into and out of problematic drug use.eng
dc.description.indexMEDLINEeng
dc.description.sponsorshipUnited States National Institute of Mental Health [R01 MH070884]
dc.description.sponsorshipJohn D. and Catherine T. MacArthur Foundation
dc.description.sponsorshipPfizer Foundation
dc.description.sponsorshipUS Public Health Service [R13-MH066849, R01-MH069864, R01 DA016558]
dc.description.sponsorshipFogarty International Center [FIRCA R03-TW006481]
dc.description.sponsorshipPan American Health Organization
dc.description.sponsorshipEli Lilly and Company
dc.description.sponsorshipOrtho-McNeil Pharmaceutical Inc
dc.description.sponsorshipBristol-Myers Squibb
dc.description.sponsorshipAustralian National Health and Medical Research Council [1081984]
dc.description.sponsorshipNational Health and Medical Research Council Senior Principal Research Fellowship [1135991]
dc.description.sponsorshipNational Institute on Drug Abuse [R01 DA044170-02]
dc.description.sponsorshipAustralian Government Department of Health and Ageing
dc.description.sponsorshipArgentinian Ministry of Health (Ministerio de Salud de la Nacion)
dc.description.sponsorshipState of Sao Paulo Research Foundation [03/00204-3]
dc.description.sponsorshipMinistry of Health
dc.description.sponsorshipNational Center for Public Health Protection
dc.description.sponsorshipMinistry of Social Protection
dc.description.sponsorshipCenter for Excellence on Research in Mental Health (at CES University)
dc.description.sponsorshipEuropean Commission [QLG5-1999-01042, SANCO 2004123, EAHC 20081308]
dc.description.sponsorshipMinisterio de Ciencia y Tecnologia, Spain [SAF 2000-158-CE]
dc.description.sponsorshipGeneralitat de Catalunya [2017 SGR 452, 2014 SGR 748]
dc.description.sponsorshipFondo de Investigacion Sanitaria, Instituto de Salud Carlos III, Spain [FIS 00/0028]
dc.description.sponsorshipGlaxoSmithKline
dc.description.sponsorshipJapanese and European Funds through United Nations Development Group Iraq Trust Fund
dc.description.sponsorshipIsrael National Institute for Health Policy and Health Services Research
dc.description.sponsorshipNational Insurance Institute of Israel
dc.description.sponsorshipJapan Ministry of Health, Labour andWelfare [H13-SHOGAI-023, H14-TOKUBETSU-026, H16-KOKORO-013, H25-SEISHIN-IPPAN-006]
dc.description.sponsorshipLebanese Ministry of Public Health
dc.description.sponsorshipNational Institutes of Health/Fogarty International Center [R03 TW006481-01]
dc.description.sponsorshipAlgorithm
dc.description.sponsorshipAstraZeneca
dc.description.sponsorshipBenta
dc.description.sponsorshipBella Pharma
dc.description.sponsorshipEli Lilly
dc.description.sponsorshipGlaxo Smith Kline
dc.description.sponsorshipLundbeck
dc.description.sponsorshipNovartis
dc.description.sponsorshipOmniPharma
dc.description.sponsorshipPfizer
dc.description.sponsorshipPhenicia
dc.description.sponsorshipServier
dc.description.sponsorshipUPO
dc.description.sponsorshipNational Institute of Psychiatry Ramon de la Fuente [INPRFMDIES 4280]
dc.description.sponsorshipNational Council on Science and Technology [CONACyT-G30544-H]
dc.description.sponsorshipNew Zealand Ministry of Health
dc.description.sponsorshipHealth Research Council
dc.description.sponsorshipWorld Health Organization Geneva
dc.description.sponsorshipWorld Health Organization Nigeria
dc.description.sponsorshipFederal Ministry of Health in Abuja, Nigeria
dc.description.sponsorshipHealth & Social Care Research & Development Division of the Public Health Agency
dc.description.sponsorshipNational Institute of Health of the Ministry of Health of Peru
dc.description.sponsorshipEuropean Economic Area Financial Mechanism [PL 0256]
dc.description.sponsorshipNorwegian Financial Mechanism
dc.description.sponsorshipPolish Ministry of Health
dc.description.sponsorshipUS National Institute of Mental Health [R01-MH059575, RO1-MH61905]
dc.description.sponsorshipNational Institute of Drug Abuse
dc.description.sponsorshipSouth African Department of Health
dc.description.sponsorshipRegional Health Authority of Murcia (Servicio Murciano de Salud)
dc.description.sponsorshipFundacion para la Formacion e Investigacion Sanitarias of Murcia
dc.description.sponsorshipNational Institute of Mental Health [U01-MH60220]
dc.description.sponsorshipRobertWood Johnson Foundation [044708]
dc.description.sponsorshipBrazilian Council for Scientific and Technological Development (CNPq) [307784/2016-9]
dc.description.sponsorshipMedical Research Council of South Africa
dc.description.sponsorshipWorld Health Organization Lebanon
dc.description.sponsorshipAlcohol Advisory Council
dc.description.sponsorshipUniversity of Michigan
dc.description.sponsorshipRegional Health Authority of Murcia (Consejeria de Sanidad y Politica Social)
dc.description.sponsorshipPiedmont Region (Italy)
dc.description.sponsorshipInstituto de Salud Carlos III (CIBER) [CB06/02/0046, RETICS RD06/0011 REM-TAP]
dc.description.sponsorshipSubstance Abuse and Mental Health Services Administration
dc.description.sponsorshipJohnWAlden Trust
dc.identifier.citationJAMA PSYCHIATRY, v.76, n.7, p.708-720, 2019
dc.identifier.doi10.1001/jamapsychiatry.2019.0163
dc.identifier.eissn2168-6238
dc.identifier.issn2168-622X
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/33646
dc.language.isoeng
dc.publisherAMER MEDICAL ASSOCeng
dc.relation.ispartofJama Psychiatry
dc.rightsrestrictedAccesseng
dc.rights.holderCopyright AMER MEDICAL ASSOCeng
dc.subject.othernational epidemiologic surveyeng
dc.subject.otheriv alcohol dependenceeng
dc.subject.otherage-of-onseteng
dc.subject.otherunited-stateseng
dc.subject.otherpsychiatric-disorderseng
dc.subject.othercannabis useeng
dc.subject.otherprevalenceeng
dc.subject.otherpredictorseng
dc.subject.othermarijuanaeng
dc.subject.otherperiodeng
dc.subject.wosPsychiatryeng
dc.titleAssociation of Cohort and Individual Substance Use With Risk of Transitioning to Drug Use, Drug Use Disorder, and Remission From Disorder: Findings From the World Mental Health Surveyseng
dc.typearticleeng
dc.type.categoryoriginal articleeng
dc.type.versionpublishedVersioneng
dspace.entity.typePublication
hcfmusp.affiliation.countryIraque
hcfmusp.affiliation.countryEspanha
hcfmusp.affiliation.countryIrlanda
hcfmusp.affiliation.countryArgentina
hcfmusp.affiliation.countryItália
hcfmusp.affiliation.countryHolanda
hcfmusp.affiliation.countryBélgica
hcfmusp.affiliation.countryNigéria
hcfmusp.affiliation.countryChina
hcfmusp.affiliation.countryBulgária
hcfmusp.affiliation.countryLíbano
hcfmusp.affiliation.countryPolônia
hcfmusp.affiliation.countryFrança
hcfmusp.affiliation.countryIsrael
hcfmusp.affiliation.countryMéxico
hcfmusp.affiliation.countryColômbia
hcfmusp.affiliation.countryNova Zelândia
hcfmusp.affiliation.countryÁfrica do Sul
hcfmusp.affiliation.countryJapão
hcfmusp.affiliation.countryPortugal
hcfmusp.affiliation.countrySuíça
hcfmusp.affiliation.countryEstados Unidos
hcfmusp.affiliation.countryRomênia
hcfmusp.affiliation.countryDinamarca
hcfmusp.affiliation.countryAustrália
hcfmusp.affiliation.countryisoau
hcfmusp.affiliation.countryisous
hcfmusp.affiliation.countryisoiq
hcfmusp.affiliation.countryisoes
hcfmusp.affiliation.countryisoie
hcfmusp.affiliation.countryisoar
hcfmusp.affiliation.countryisoit
hcfmusp.affiliation.countryisonl
hcfmusp.affiliation.countryisobe
hcfmusp.affiliation.countryisong
hcfmusp.affiliation.countryisocn
hcfmusp.affiliation.countryisobg
hcfmusp.affiliation.countryisolb
hcfmusp.affiliation.countryisopl
hcfmusp.affiliation.countryisofr
hcfmusp.affiliation.countryisoil
hcfmusp.affiliation.countryisomx
hcfmusp.affiliation.countryisoco
hcfmusp.affiliation.countryisonz
hcfmusp.affiliation.countryisoza
hcfmusp.affiliation.countryisojp
hcfmusp.affiliation.countryisopt
hcfmusp.affiliation.countryisoch
hcfmusp.affiliation.countryisoro
hcfmusp.affiliation.countryisodk
hcfmusp.author.externalDEGENHARDT, Louisa:Univ New South Wales, Natl Drug & Alcohol Res Ctr, Sydney, NSW, Australia
hcfmusp.author.externalBHARAT, Chrianna:Univ New South Wales, Natl Drug & Alcohol Res Ctr, Sydney, NSW, Australia
hcfmusp.author.externalGLANTZ, Meyer D.:Natl Inst Drug Abuse, Dept Epidemiol Serv & Prevent Res, NIH, Bethesda, MD USA
hcfmusp.author.externalSAMPSON, Nancy A.:Harvard Med Sch, Dept Hlth Care Policy, Boston, MA 02115 USA
hcfmusp.author.externalAL-HAMZAWI, Ali:Al Qadisiya Univ, Coll Med, Diwaniya Governorate, Iraq; Al Qadisiya Univ, Coll Med, Diwaniya Governorate, Iraq
hcfmusp.author.externalALONSO, Jordi:Inst Hosp del Mar Invest Med, Hlth Serv Res Unit, Barcelona, Spain; Ctr Invest Biomed Red Epidemiol & Salud Publ, Barcelona, Spain; Pompeu Fabra Univ, Barcelona, Spain; Ctr Invest Biomed ERed Epidemiol & Salud Publ, Murcia, Spain; Hosp del Mar, Med Res Inst, Hlth Serv Res Unit, Barcelona, Spain
hcfmusp.author.externalBUNTING, Brendan:Ulster Univ, Sch Psychol, Coleraine, Londonderry, North Ireland
hcfmusp.author.externalCIA, Alfredo:Anxiety Disorders Ctr, Buenos Aires, DF, Argentina
hcfmusp.author.externalGIROLAMO, Giovanni de:IRCCS Ist Ctr San Giovanni Dio Fatebenefratelli, Brescia, Italy
hcfmusp.author.externalJONGE, Peter De:Univ Groningen, Dept Psychol, Dev Psychol, Groningen, Netherlands; Univ Med Ctr Groningen, Dept Psychiat, Interdisciplinary Ctr Psychopathol & Emot Regulat, Groningen, Netherlands
hcfmusp.author.externalDEMYTTENAERE, Koen:Katholieke Univ Leuven, Univ Hosp Gasthuisberg, Dept Psychiat, Leuven, Belgium
hcfmusp.author.externalGUREJE, Oye:Univ Coll Hosp, Dept Psychiat, Ibadan, Nigeria
hcfmusp.author.externalHARO, Josep Maria:Univ Barcelona, Ctr Invest Biomed Red Salud Mental, Parc Sanitari St Joan de Deu, Barcelona, Spain
hcfmusp.author.externalHARRIS, Meredith G.:Univ Queensland, Sch Publ Hlth, Brisbane, Qld, Australia; Pk Ctr Mental Hlth, Queensland Ctr Mental Hlth Res, Brisbane, Qld, Australia
hcfmusp.author.externalHE, Yanling:Shanghai Jiao Tong Univ, Sch Med, Shanghai Mental Hlth Ctr, Shanghai, Peoples R China
hcfmusp.author.externalHINKOV, Hristo:Natl Ctr Publ Hlth & Analyses, Sofia, Bulgaria
hcfmusp.author.externalKARAM, Aimee Nasser:Inst Dev Res Advocacy & Appl Care, Beirut, Lebanon
hcfmusp.author.externalKARAM, Elie G.:Inst Dev Res Advocacy & Appl Care, Beirut, Lebanon; Balamand Univ, Fac Med, Dept Psychiat & Clin Psychol, Beirut, Lebanon; St George Hosp Univ, Med Ctr, Dept Psychiat & Clin Psychol, Beirut, Lebanon
hcfmusp.author.externalKIEJNA, Andrzej:Wroclaw Med Univ, Wroclaw, Poland; Univ Lower Silesia, Wroclaw, Poland
hcfmusp.author.externalKOVESS-MASFETY, Viviane:Paris Descartes Univ, Ecole Hautes Etud Sante Publ, EA 4057, Paris, France
hcfmusp.author.externalLASEBIKAN, Victor:Univ Ibadan, Coll Med, Dept Psychiat, Ibadan, Nigeria
hcfmusp.author.externalLEE, Sing:Chinese Univ Hong Kong, Dept Psychiat, Tai Po, Hong Kong, Peoples R China
hcfmusp.author.externalLEVINSON, Daphna:Minist Hlth, Mental Hlth Serv, Jerusalem, Israel
hcfmusp.author.externalMEDINA-MORA, Maria Elena:Natl Inst Psychiat Ramon Fuente Muniz, Mexico City, DF, Mexico
hcfmusp.author.externalMNEIMNEH, Zeina:Univ Michigan, Inst Social Res, Survey Res Ctr, Ann Arbor, MI USA
hcfmusp.author.externalNAVARRO-MATEU, Fernando:Serv Murciano Salud, Unidad Docencia Invest & Formac Salud Mental, Murcia, Spain; Inst Murciano Invest Biosanitaria Virgen Arrixaca, Murcia, Spain; Ctr Invest Biomed ERed Epidemiol & Salud Publ, Murcia, Spain
hcfmusp.author.externalPIAZZA, Marina:Univ Peruana Cayetano Heredia, Lima, Peru; Colegio Mayor Cundinamarca Univ, Fac Social Sci, Bogota, Colombia
hcfmusp.author.externalPOSADA-VILLA, Jose:Colegio Mayor Cundinamarca Univ, Fac Social Sci, Bogota, Colombia
hcfmusp.author.externalSCOTT, Kate:Univ Otago, Dept Psychol Med, Dunedin, Otago, New Zealand
hcfmusp.author.externalSTEIN, Dan J.:Univ Cape Town, South African Med Council Res Unit Risk & Resilie, Dept Psychiat & Mental Hlth, Neurosci Inst, Cape Town, South Africa; Groote Schuur Hosp, Cape Town, South Africa; Univ Cape Town, Dept Psychiat & Mental Hlth, Cape Town, South Africa; Univ Cape Town, South African Med Council Res Unit Risk & Resilie, Cape Town, South Africa; Groote Schuur Hosp, Cape Town, South Africa
hcfmusp.author.externalTACHIMORI, Hisateru:Natl Ctr Neurol & Psychiat, Natl Inst Mental Hlth, Kodaira, Tokyo, Japan
hcfmusp.author.externalTINTLE, Nathan:Dordt Coll, Dept Math Stat & Comp Sci, Sioux Ctr, IA USA
hcfmusp.author.externalTORRES, Yolanda:CES Univ, Ctr Excellence Res Mental Hlth, Medellin, Colombia; CES Univ, Ctr Excellence Res Mental Hlth, Medellin, Colombia
hcfmusp.author.externalKESSLER, Ronald C.:Harvard Med Sch, Dept Hlth Care Policy, Boston, MA 02115 USA
hcfmusp.author.externalAGUILAR-GAXIOLA, Sergio:Univ Calif Davis, Ctr Reducing Hlth Dispar, Hlth Syst, Sacramento, CA 95817 USA
hcfmusp.author.externalAL-HAMZAWI, Ali:Al Qadisiya Univ, Coll Med, Diwaniya Governorate, Iraq; Al Qadisiya Univ, Coll Med, Diwaniya Governorate, Iraq
hcfmusp.author.externalAL-KAISY, Mohammed Salih:Ibn Seena Teaching Hosp, Day Care & Rehabil Ctr, Mosul, Iraq
hcfmusp.author.externalALONSO, Jordi:Inst Hosp del Mar Invest Med, Hlth Serv Res Unit, Barcelona, Spain; Ctr Invest Biomed Red Epidemiol & Salud Publ, Barcelona, Spain; Pompeu Fabra Univ, Barcelona, Spain; Ctr Invest Biomed ERed Epidemiol & Salud Publ, Murcia, Spain; Hosp del Mar, Med Res Inst, Hlth Serv Res Unit, Barcelona, Spain
hcfmusp.author.externalBENJET, Corina:Natl Inst Psychiat Ramon Fuente, Dept Epidemiol & Psychosocial Res, Mexico City, DF, Mexico
hcfmusp.author.externalBORGES, Guilherme:Inst Nacl Psiquiatria, Calzada Mexico Xochimilco 101, Mexico City, DF, Mexico
hcfmusp.author.externalBROMET, Evelyn J.:SUNY Stony Brook, Dept Psychiat, Sch Med, Stony Brook, NY 11794 USA
hcfmusp.author.externalBRUFFAERTS, Ronny:Katholieke Univ Leuven, Univ Psychiatr Centrum, Leuven, Belgium
hcfmusp.author.externalBUNTING, Brendan:Ulster Univ, Sch Psychol, Coleraine, Londonderry, North Ireland
hcfmusp.author.externalALMEIDA, Jose Miguel Caldas de:Univ Nova Lisboa, Chron Dis Res Ctr, Lisbon, Portugal; Univ Nova Lisboa, Fac Ciencias Med, Dept Mental Hlth, Lisbon, Portugal
hcfmusp.author.externalCARDOSO, Graca:NOVA Univ Lisbon, NOVA Med Sch, Lisbon Inst Global Mental Hlth, Lisbon, Portugal; NOVA Univ Lisbon, NOVA Med Sch, Chron Dis Res Ctr, Lisbon, Portugal
hcfmusp.author.externalCHATTERJI, Somnath:WHO, Dept Informat Evidence & Res, Geneva, Switzerland
hcfmusp.author.externalCIA, Alfredo H.:Anxiety Disorders Ctr, Buenos Aires, DF, Argentina
hcfmusp.author.externalDEGENHARDT, Louisa:Univ New South Wales, Natl Drug & Alcohol Res Ctr, Sydney, NSW, Australia
hcfmusp.author.externalDEMYTTENAERE, Koen:Katholieke Univ Leuven, Univ Hosp Gasthuisberg, Dept Psychiat, Leuven, Belgium
hcfmusp.author.externalFLORESCU, Silvia:Natl Sch Publ Hlth Management & Dev, Bucharest, Romania
hcfmusp.author.externalGIROLAMO, Giovanni de:IRCCS Ist Ctr San Giovanni Dio Fatebenefratelli, Brescia, Italy
hcfmusp.author.externalGUREJE, Oye:Univ Coll Hosp, Dept Psychiat, Ibadan, Nigeria
hcfmusp.author.externalHARO, Josep Maria:Univ Barcelona, Ctr Invest Biomed Red Salud Mental, Parc Sanitari St Joan de Deu, Barcelona, Spain
hcfmusp.author.externalHINKOV, Hristo:Natl Ctr Publ Hlth & Analyses, Sofia, Bulgaria
hcfmusp.author.externalHU, Chi-yi:Natl Ctr Publ Hlth & Analyses, Sofia, Bulgaria
hcfmusp.author.externalJONGE, Peter de:Univ Med Ctr Groningen, Dept Psychiat, Interdisciplinary Ctr Psychopathol & Emot Regulat, Groningen, Netherlands
hcfmusp.author.externalKARAM, Aimee Nasser:Inst Dev Res Advocacy & Appl Care, Beirut, Lebanon
hcfmusp.author.externalKARAM, Elie G.:Inst Dev Res Advocacy & Appl Care, Beirut, Lebanon; Balamand Univ, Fac Med, Dept Psychiat & Clin Psychol, Beirut, Lebanon; St George Hosp Univ, Med Ctr, Dept Psychiat & Clin Psychol, Beirut, Lebanon
hcfmusp.author.externalKAWAKAMI, Norito:Univ Tokyo, Sch Publ Hlth, Dept Mental Hlth, Tokyo, Japan
hcfmusp.author.externalKESSLER, Ronald C.:Harvard Med Sch, Dept Hlth Care Policy, Boston, MA 02115 USA
hcfmusp.author.externalKIEJNA, Andrzej:Wroclaw Med Univ, Wroclaw, Poland; Univ Lower Silesia, Wroclaw, Poland
hcfmusp.author.externalKOVESS-MASFETY, Viviane:Paris Descartes Univ, Ecole Hautes Etud Sante Publ, EA 4057, Paris, France
hcfmusp.author.externalLEE, Sing:Chinese Univ Hong Kong, Dept Psychiat, Tai Po, Hong Kong, Peoples R China
hcfmusp.author.externalLEPINE, Jean-Pierre:Hop Lariboisiere Fernand Widal, AP HP, Paris, France; Univ Paris Descartes Paris Diderot, Paris, France; Inst Natl Sante & Rech Med, UMR S 1144, Paris, France
hcfmusp.author.externalLEVINSON, Daphna:Minist Hlth, Mental Hlth Serv, Jerusalem, Israel
hcfmusp.author.externalMCGRATH, John:Univ Queensland, Queensland Brain Inst, St Lucia, Qld, Australia; Aarhus Univ, Natl Ctr Register Based Res, Aarhus, Denmark
hcfmusp.author.externalMNEIMNEH, Zeina:Univ Michigan, Inst Social Res, Survey Res Ctr, Ann Arbor, MI USA
hcfmusp.author.externalMOSKALEWICZ, Jacek:Inst Psychiat & Neurol, Warsaw, Poland
hcfmusp.author.externalNAVARRO-MATEU, Fernando:Serv Murciano Salud, Unidad Docencia Invest & Formac Salud Mental, Murcia, Spain; Inst Murciano Invest Biosanitaria Virgen Arrixaca, Murcia, Spain; Ctr Invest Biomed ERed Epidemiol & Salud Publ, Murcia, Spain
hcfmusp.author.externalPENNELL, Beth-Ellen:Univ Michigan, Inst Social Res, Survey Res Ctr, Ann Arbor, MI USA
hcfmusp.author.externalPIAZZA, Marina:Univ Peruana Cayetano Heredia, Lima, Peru; Colegio Mayor Cundinamarca Univ, Fac Social Sci, Bogota, Colombia
hcfmusp.author.externalPOSADA-VILLA, Jose:Colegio Mayor Cundinamarca Univ, Fac Social Sci, Bogota, Colombia
hcfmusp.author.externalSCOTT, Kate M.:Univ Otago, Dept Psychol Med, Dunedin, Otago, New Zealand
hcfmusp.author.externalSLADE, Tim:Univ New South Wales, Natl Drug & Alcohol Res Ctr, Sydney, NSW, Australia
hcfmusp.author.externalSTAGNARO, Juan Carlos:Univ Buenos Aires, Fac Med, Dept Psiquiatria & Salud Mental, Buenos Aires, DF, Argentina
hcfmusp.author.externalSTEIN, Dan J.:Univ Cape Town, South African Med Council Res Unit Risk & Resilie, Dept Psychiat & Mental Hlth, Neurosci Inst, Cape Town, South Africa; Groote Schuur Hosp, Cape Town, South Africa; Univ Cape Town, Dept Psychiat & Mental Hlth, Cape Town, South Africa; Univ Cape Town, South African Med Council Res Unit Risk & Resilie, Cape Town, South Africa; Groote Schuur Hosp, Cape Town, South Africa
hcfmusp.author.externalHAVE, Margreet ten:Netherlands Inst Mental Hlth & Addict, Trimbos Inst, Utrecht, Netherlands
hcfmusp.author.externalTORRES, Yolanda:CES Univ, Ctr Excellence Res Mental Hlth, Medellin, Colombia; CES Univ, Ctr Excellence Res Mental Hlth, Medellin, Colombia
hcfmusp.author.externalVIANA, Maria Carmen:Univ Fed Espirito Santo, Postgrad Program Publ Hlth, Dept Social Med, Vitoria, Brazil
hcfmusp.author.externalWHITEFORD, Harvey:Queensland Ctr Mental Hlth Res, Brisbane, Qld, Australia
hcfmusp.author.externalWILLIAMS, David R.:Harvard TH Chan Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA USA
hcfmusp.author.externalWOJTYNIAK, Bogdan:Natl Inst Hyg, Natl Inst Publ Hlth, Ctr Monitoring & Analyses Populat Hlth, Warsaw, Poland
hcfmusp.citation.scopus24
hcfmusp.contributor.author-fmusphcLAURA HELENA SILVEIRA GUERRA DE ANDRADE
hcfmusp.description.beginpage708
hcfmusp.description.endpage720
hcfmusp.description.issue7
hcfmusp.description.volume76
hcfmusp.origemWOS
hcfmusp.origem.pubmed30865282
hcfmusp.origem.scopus2-s2.0-85062949247
hcfmusp.origem.wosWOS:000477894200010
hcfmusp.publisher.cityCHICAGOeng
hcfmusp.publisher.countryUSAeng
hcfmusp.relation.referenceAbdin E, 2014, ALCOHOL ALCOHOLISM, V49, P103, DOI 10.1093/alcalc/agt126eng
hcfmusp.relation.referenceAnthony James C., 1994, Experimental and Clinical Psychopharmacology, V2, P244, DOI 10.1037/1064-1297.2.3.244eng
hcfmusp.relation.referenceBehrendt S, 2009, DRUG ALCOHOL DEPEN, V99, P68, DOI 10.1016/j.drugalcdep.2008.06.014eng
hcfmusp.relation.referenceBreslau N, 2004, BIOL PSYCHIAT, V55, P69, DOI 10.1016/S0006-3223(03)00317-2eng
hcfmusp.relation.referenceButterworth P, 2014, DRUG ALCOHOL REV, V33, P555, DOI 10.1111/dar.12183eng
hcfmusp.relation.referenceCoffey C, 2003, BRIT J PSYCHIAT, V182, P330, DOI 10.1192/bjp.182.4.330eng
hcfmusp.relation.referenceCompton WM, 2013, AM J PSYCHIAT, V170, P660, DOI 10.1176/appi.ajp.2012.12060737eng
hcfmusp.relation.referenceDegenhardt L, 2018, MENTAL DISORDERS WOR, P243, DOI [10.1017/9781316336168.017, DOI 10.1017/9781316336168.017]eng
hcfmusp.relation.referenceDegenhardt L, 2018, DRUG ALCOHOL REV, V37, P546, DOI 10.1111/dar.12679eng
hcfmusp.relation.referenceDegenhardt L, 2016, LANCET PSYCHIAT, V3, P251, DOI 10.1016/S2215-0366(15)00508-8eng
hcfmusp.relation.referenceFlorez-Salamanca L, 2013, AM J DRUG ALCOHOL AB, V39, P168, DOI 10.3109/00952990.2013.772618eng
hcfmusp.relation.referenceGrant BF, 1997, J STUD ALCOHOL, V58, P464, DOI 10.15288/jsa.1997.58.464eng
hcfmusp.relation.referenceGrant BF, 1996, J SUBST ABUSE, V8, P195, DOI 10.1016/S0899-3289(96)90249-7eng
hcfmusp.relation.referenceGrucza RA, 2008, ALCOHOL CLIN EXP RES, V32, P763, DOI 10.1111/j.1530-0277.2008.00635.xeng
hcfmusp.relation.referenceHall WD, 2016, LANCET PSYCHIAT, V3, P265, DOI 10.1016/S2215-0366(16)00013-4eng
hcfmusp.relation.referenceHaro JM, 2006, INT J METH PSYCH RES, V15, P167, DOI 10.1002/mpr.196eng
hcfmusp.relation.referenceHasin DS, 2004, ARCH GEN PSYCHIAT, V61, P891, DOI 10.1001/archpsyc.61.9.891eng
hcfmusp.relation.referenceJohnson EO, 2005, INT J METH PSYCH RES, V14, P119, DOI 10.1002/mpr.2eng
hcfmusp.relation.referenceJohnson RA, 2000, SUBST USE MISUSE, V35, P925, DOI 10.3109/10826080009148427eng
hcfmusp.relation.referenceKalaydjian A, 2009, COMPR PSYCHIAT, V50, P299, DOI 10.1016/j.comppsych.2008.09.012eng
hcfmusp.relation.referenceKerr WC, 2009, ADDICTION, V104, P27, DOI 10.1111/j.1360-0443.2008.02391.xeng
hcfmusp.relation.referenceKessler R. C., 2008, WHO MENTAL HLTH SURVeng
hcfmusp.relation.referenceKessler RC, 2004, INT J METH PSYCH RES, V13, P93, DOI 10.1002/mpr.168eng
hcfmusp.relation.referenceKESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8eng
hcfmusp.relation.referenceKeyes KM, 2011, ADDICTION, V106, P1790, DOI 10.1111/j.1360-0443.2011.03485.xeng
hcfmusp.relation.referenceLago L, 2017, INT J METH PSYCH RES, V26, DOI 10.1002/mpr.1557eng
hcfmusp.relation.referenceLarance B, 2018, DRUG ALCOHOL DEPEN, V191, P145, DOI 10.1016/j.drugalcdep.2018.03.056eng
hcfmusp.relation.referenceLee S, 2009, ADDICTION, V104, P1313, DOI 10.1111/j.1360-0443.2009.02595.xeng
hcfmusp.relation.referenceLopez-Quintero C, 2011, DRUG ALCOHOL DEPEN, V115, P120, DOI 10.1016/j.drugalcdep.2010.11.004eng
hcfmusp.relation.referenceOMALLEY PM, 1988, AM J PUBLIC HEALTH, V78, P1315, DOI 10.2105/AJPH.78.10.1315eng
hcfmusp.relation.referencePollard J. W., 2000, J COLL STUDENT PSYCH, V14, P5, DOI 10.1300/J035v14n03_03eng
hcfmusp.relation.referenceRice JP, 2003, ALCOHOL CLIN EXP RES, V27, P93, DOI 10.1097/01.ALC.0000047303.89421.AAeng
hcfmusp.relation.referenceRidenour TA, 2006, ADDICT BEHAV, V31, P962, DOI 10.1016/j.addbeh.2006.03.015eng
hcfmusp.relation.referenceShillington AM, 2012, J CHILD ADOLES SUBST, V21, P333, DOI 10.1080/1067828X.2012.710026eng
hcfmusp.relation.referenceSilveira CM, 2011, ALCOHOL ALCOHOLISM, V46, P324, DOI 10.1093/alcalc/agr007eng
hcfmusp.relation.referenceSuliman S, 2010, J STUD ALCOHOL DRUGS, V71, P695, DOI 10.15288/jsad.2010.71.695eng
hcfmusp.relation.referenceWEISS RD, 1988, J NERV MENT DIS, V176, P719, DOI 10.1097/00005053-198812000-00004eng
hcfmusp.relation.referenceWells JE, 2011, SUBST USE MISUSE, V46, P1169, DOI 10.3109/10826084.2011.553659eng
hcfmusp.scopus.lastupdate2024-05-10
relation.isAuthorOfPublicationfb08711c-e402-4736-ae73-151116153731
relation.isAuthorOfPublication.latestForDiscoveryfb08711c-e402-4736-ae73-151116153731
Arquivos
Pacote Original
Agora exibindo 1 - 1 de 1
Nenhuma Miniatura disponível
Nome:
art_DEGENHARDT_Association_of_Cohort_and_Individual_Substance_Use_With_2019.PDF
Tamanho:
286.61 KB
Formato:
Adobe Portable Document Format
Descrição:
publishedVersion (English)
Baixar
Coleções
Artigos e Materiais de Revistas Científicas - HC/IPq
Artigos e Materiais de Revistas Científicas - LIM/23
Artigos e Materiais de Revistas Científicas - ODS/03